| Modification | Date |
| Change to section 4.5 - Interaction with other medicinal products and other forms of interaction | 06/11/2009 11:03:55 |
| Change to section 10 date of revision of the text | 06/11/2009 11:03:55 |
| Change to section 9 - Date of first Authorisation/renewal of the Authorisation | 06/11/2009 11:03:55 |
| Change to section 8 - MARKETING AUTHORISATION NUMBER(S) | 06/11/2009 11:03:55 |
| Change to section 7 - Marketing Authorisation Holder | 07/04/2009 15:01:22 |
| Change to section 7 - Marketing Authorisation Holder | 18/09/2007 14:55:31 |
| Change to section 10 (date of (partial) revision of the text | 19/09/2006 13:29:56 |
| Change to section 4.9 - Overdose | 04/04/2005 16:31:35 |
| Change to section 4.8 - Undesirable Effects | 04/04/2005 16:31:35 |
| Change to section 4.6 - Pregnancy and Lactation | 04/04/2005 16:31:35 |
| Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction | 04/04/2005 16:31:35 |
| Change to section 4.4 - Special Warnings and Precautions for Use | 04/04/2005 16:31:35 |
| Change to section 4.3 - Contra-indications | 04/04/2005 16:31:35 |
| Change to section 10 (date of (partial) revision of the text | 04/08/2004 19:37:55 |
| Change to section 7 - Marketing Authorisation Holder | 26/09/2002 18:16:36 |
|